as 10-20-2025 3:51pm EST
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Founded: | 1904 | Country: | United States |
Employees: | N/A | City: | RADNOR |
Market Cap: | 8.5B | IPO Year: | 2019 |
Target Price: | $15.83 | AVG Volume (30 days): | 10.2M |
Analyst Decision: | Buy | Number of Analysts: | 12 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.01 | EPS Growth: | 94.25 |
52 Week Low/High: | $10.82 - $26.14 | Next Earning Date: | 10-29-2025 |
Revenue: | $6,665,800,000 | Revenue Growth: | -2.34% |
Revenue Growth (this year): | -0.55% | Revenue Growth (next year): | 2.25% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SUMME GREGORY L | AVTR | N/A | Aug 21 '25 | Buy | $12.56 | 100,000 | $1,256,000.00 | 200,000 |
AVTR Breaking Stock News: Dive into AVTR Ticker-Specific Updates for Smart Investing
PR Newswire
7 days ago
StockStory
17 days ago
MT Newswires
17 days ago
Simply Wall St.
17 days ago
PR Newswire
17 days ago
StockStory
18 days ago
Simply Wall St.
18 days ago
Insider Monkey
19 days ago
The information presented on this page, "AVTR Avantor Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.